Attached files
file | filename |
---|---|
EX-99.1 - PRESS RELEASE - GILLA INC. | glla_ex991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
DATE OF EARLIEST EVENT REPORTED – October 2,
2017
GILLA INC.
(Exact
Name of Registrant as Specified in its Charter)
NEVADA
|
|
000-28107
|
|
88-0335710
|
(State
or other jurisdiction of
|
|
(Commission
|
|
(IRS
Employer
|
incorporation)
|
|
File
Number)
|
|
Identification
Number)
|
475 Fentress Blvd., Unit L, Daytona Beach, Florida
32114
(Address of principal executive offices)
(416) 843-2881
(Registrant’s
telephone number, including area code)
N/A
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
|
Written
communications pursuant to Rule 425 under the Securities
Act
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange
Act
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange
Act
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange
Act
|
Indicate
by check mark whether the registrant
is an emerging growth company as defined in in Rule 405 of
the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of
this chapter).
Emerging
growth company ☐
If an
emerging growth company, indicate by checkmark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act.
☐
Item 8.01
Other Events.
On
October 2, 2017, Gilla Inc. (“Gilla” or the
“Company”) issued a press release announcing that the
Company is working jointly with CannTrust Holdings Inc.
(“CannTrust”), a licensed producer of medical cannabis
under the Health Canada Access to Cannabis for Medical Purposes
Regulation (Canada) program, to develop both private-label and
branded cannabis vapor solutions for CannTrust to produce and
distribute in Canada though their authorized distribution
channels.
A copy
of such press release is attached hereto as Exhibit 99.1 and
incorporated herein by reference.
Item 9.01
Financial Statements and Exhibits.
(d)
Exhibits
Exhibit No.
|
Description
|
Press
Release dated October 2, 2017 from Gilla Inc.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
GILLA
INC.
|
|
|
|
|
|
|
Dated: October 6,
2017
|
By:
|
/s/
Graham
Simmonds
|
|
|
Name:
|
Graham
Simmonds
|
|
|
Title:
|
Chief Executive
Officer
|
|